Pathfinder Therapeutics update

Pathfinder Therapeutics, the Nashville-based VU spinoff that focuses on open and minimally invasive surgery using image-guided technologies, announced Sloan-Kettering and other universities are participating in clinical trials. The release is here. Related stories here.

Surgical robots do battle

In Chattanooga, the Times Free Press reports on the "arms race" driving increased use of surgical robots, with focus on the da Vinci system. Related TFP article here. Closer to home, VNC reported earlier on Pathfinder Therapeutics.

Pathfinder: perfect match from VU

At my age, I tend to think of great pairings like Galloway and Stefansic at Pathfinder Therapeutics as more than 'coincidence'. There's multi-disciplined, polite-but-restrained Bob Galloway (at left), blazing a path in science, and often displaying what seems to be, at best, 'uneasiness' with the whole issue of commercialization. Then, there's fellow scientist Jim Stefansic, equally dedicated to expanding knowledge, who added an MBA from Belmont to complement his VU-bred scientific toolset. The future's not entirely clear for Pathfinder, but Stefansic offers a few comments on what it's like from his vantage. The story's here.

Elements Software, Brentwood

Judy Eads, a former nurse, has spent the last couple years developing software to support nurses care of long-term elderly patients. Eads' Elements Software LLC is backed by investors who own long-term care facilities. The NBJ reports in its Oct. 30 edition. Today's NBJ entrepreneurship package also includes items on Pathfinder Therapeutics, TNInvestco, TTDC, Nashville Capital Network and others.

Pathfinder Therapeutics gets CEO, hits the road

Skip Goode now gets to try his hand at capitalizing on the image-guided surgery technology of Vanderbilt University spin-out Pathfinder Therapeutics. Goode brings a long record in medical devices to the challenge. He and other PTI management are telling the story at several venues, this week. Our story's here.